The Influence of Early and Continuous Exposure of Infants to Cow's Milk Formula on the Prevention of Milk Allergy
Primary Purpose
Cow Milk Allergy, Newborns
Status
Unknown status
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
cow's milk formula
Sponsored by
About this trial
This is an interventional prevention trial for Cow Milk Allergy focused on measuring Allergy, Cow's milk, breast feeding, Cow's milk formula, prevention
Eligibility Criteria
Inclusion Criteria:
- Term and near term newborns (gestational age of at least 36 weeks)
- normal birth weight
- normal perinatal follow-up (physiological neonatal jaundice is not an exclusion criteria)
- without congenital defects
Exclusion Criteria:
- Preterm newborns
- Congenital defects
- Newborn suffering from acute event
Sites / Locations
- Meir medical centerRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
No Intervention
No Intervention
Active Comparator
Active Comparator
Arm Label
Exclusive breast feeding
Exclusive CMF feeding
Breast feeding with small amount of CMF
Breast feeding with one meal of CMF
Arm Description
Exclusive breast feeding
Exclusive CMF feeding
Breast feeding with addition (as intervention) of 20 cc of cow's milk formula (CMF) per day
Breast feeding with addition (as intervention) of one meal per day of cow's milk formula (CMF)
Outcomes
Primary Outcome Measures
The incidence of cow's milk allergy in the intervention groups
Measure the rate of cow's milk allergy infants in each group and compare the rate of allergy between the groups.
Secondary Outcome Measures
Full Information
NCT ID
NCT02785679
First Posted
May 25, 2016
Last Updated
April 13, 2021
Sponsor
Meir Medical Center
Collaborators
Schneider Children's Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02785679
Brief Title
The Influence of Early and Continuous Exposure of Infants to Cow's Milk Formula on the Prevention of Milk Allergy
Official Title
The Influence of Early and Continuous Exposure of Infants to Cow's Milk Formula on the Prevention of Milk Allergy
Study Type
Interventional
2. Study Status
Record Verification Date
April 2021
Overall Recruitment Status
Unknown status
Study Start Date
March 20, 2018 (Actual)
Primary Completion Date
August 31, 2021 (Anticipated)
Study Completion Date
December 31, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Meir Medical Center
Collaborators
Schneider Children's Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Cow's milk protein (CMP) allergy is one of the most common food allergies and potentially a fatal one. Early feeding with CMP has been considered in the past as a risk factor for development of CMP allergy in high risk infants. Although other studies argue with this assumption and suggest early exposure to CMP might be protective against atopic dermatitis and CMP allergy. A cohort study that first introduction of CMP after 15-30 days of age, raised the risk for CMP allergy.The aim of this study is to investigate if early and continuous exposure to CMF will decrease CMP allergy rate.
Detailed Description
Background: Cow's milk protein (CMP) allergy is one of the most common food allergies and potentially a fatal one. The incidence of milk allergy is 1.5-3% in the first year of life, but only 60% of the reactions are IgE mediated. CMP allergy tends to resolve in approximately 45-50% of the infants at 1 year of age, in 60-75% at the age of 2, and 85-90% at 3 years. The range for IgE mediated CMP allergy is 29-76%. A recent study suggested that the natural history of CMP allergy might have changed over time, with slower rates of resolution and a higher proportion of children with disease persisting into adolescence and adulthood. In the past it has been described that there is more incidence of CMP allergy in children from families with positive history of allergy. Early feeding with CMP has been considered in the past as a risk factor for development of CMP allergy in high risk infants. Although other studies argue with this assumption and suggest early exposure to CMP might be protective against atopic dermatitis and CMP allergy. A cohort study that first introduction of CMP after 15-30 days of age, raised the risk for CMP allergy. A recent study on peanut allergy found that continuous early exposure to peanut dramatically decreased the incidence of peanut allergy. The research in the field of food allergy and especially in CMP allergy is very alert those days. But as far as the investigators knowledge, there are no prospective studies from the first days of life that examined the influence of early and continuous exposure to cow's milk formula (CMF) on CMP allergy. The existing data related to CMP allergy is controversial and inconclusive. Thus, no one can rely on it to establish clear recommendations for parents when is the best time to combine CMF in the infants diet. Working hypothesis and aims: The aim of the study is to investigate if early and continuous exposure to CMF will decrease CMP allergy rate. The investigators assumption is that the rate of CMP allergy in the intervention groups and in infants who are only feed by CMF, will be lower than in the group of infants who are exclusively breast feed. Methods: Recruitment of 2,500 infants from first day of life and divide the participants into 4 groups: 1. Exclusive breast feeding. 2. Exclusive CMF feeding. 3. Breast feeding with 20 cc of CMF per day. 4. Breast feeding with one meal per day of CMF. The mother will complete a survey questionnaire before the labor. Infants will be followed for 1 year. During this follow-up period -the participants will be examined by an allergologist at the age of 2 month and 1 year. In between, the infants will be followed by a phone questionnaire once in a month. Specific CM IgE analysis from umbilical cord blood and skin test at 2 month of age will be performed. Inclusion criteria - Term and near term newborns (gestational age of at least 36 weeks), normal birth weight, normal perinatal follow-up and without congenital defects. Expected results: The rate of CMP allergy in the intervention groups and in the group on exclusively CMF feeding will be lower than in the group on exclusive breast feeding. Importance: If the investigators will be able to prove the study hypothesis (and even if not), it will have a significant influence on the diet recommendations for infants. Probable implications to Medicine: If the investigators will get the expected results, the recommendations that exist today for infant's feeding can be changed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cow Milk Allergy, Newborns
Keywords
Allergy, Cow's milk, breast feeding, Cow's milk formula, prevention
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
2500 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Exclusive breast feeding
Arm Type
No Intervention
Arm Description
Exclusive breast feeding
Arm Title
Exclusive CMF feeding
Arm Type
No Intervention
Arm Description
Exclusive CMF feeding
Arm Title
Breast feeding with small amount of CMF
Arm Type
Active Comparator
Arm Description
Breast feeding with addition (as intervention) of 20 cc of cow's milk formula (CMF) per day
Arm Title
Breast feeding with one meal of CMF
Arm Type
Active Comparator
Arm Description
Breast feeding with addition (as intervention) of one meal per day of cow's milk formula (CMF)
Intervention Type
Dietary Supplement
Intervention Name(s)
cow's milk formula
Intervention Description
addition of cow's milk formula in two different dosage - one only 20ml per day and one group a full meal per day
Primary Outcome Measure Information:
Title
The incidence of cow's milk allergy in the intervention groups
Description
Measure the rate of cow's milk allergy infants in each group and compare the rate of allergy between the groups.
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
2 Hours
Maximum Age & Unit of Time
2 Days
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Term and near term newborns (gestational age of at least 36 weeks)
normal birth weight
normal perinatal follow-up (physiological neonatal jaundice is not an exclusion criteria)
without congenital defects
Exclusion Criteria:
Preterm newborns
Congenital defects
Newborn suffering from acute event
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Idit Lachover- Roth, MD
Phone
972-9-7472320
Email
idit.roth@clalit.org.il
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ronit Confino- Cohen, MD
Organizational Affiliation
allergy and immunology unit, MeirMc
Official's Role
Study Director
Facility Information:
Facility Name
Meir medical center
City
Kfar Saba
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Idit Lachover - Roth, MD
Phone
972-54-3152585
Email
idit.roth@clalit.org.il
12. IPD Sharing Statement
Learn more about this trial
The Influence of Early and Continuous Exposure of Infants to Cow's Milk Formula on the Prevention of Milk Allergy
We'll reach out to this number within 24 hrs